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As of May 2013, the Diagnostic and Statistical Manual of Mental Disorders – Fifth
Edition (DSM-5)1 recognized binge eating disorder (BED) as a distinct eating disorder. To be diagnosed with BED according to DSM-5 criteria, there must be recurrent
binge eating episodes (occurring on average at least once a week for 3 months)
characterized by the consumption of larger amounts of food in a discrete period than
is typical for most people under similar circumstances and a sense of loss of control
over eating during these episodes, and there must also be marked distress associated
with the binge eating behavior.1 Unlike bulimia nervosa (BN) and anorexia nervosa of
the binge eating/purging type (AN-BE/P), there are no recurrent inappropriate compensatory behaviors, such as excessive exercise or purging, with BED.1 The DSM-5
also delineates severity criteria for BED, with the minimum level of severity based on
the number of weekly binge eating episodes (mild, 1–3; moderate, 4–7; severe, 8–13;
2213
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Abstract: The objective of this review was to examine the evidentiary basis for binge
eating disorder (BED) with reference to the Diagnostic and Statistical Manual of Mental
Disorders – Fifth Edition (DSM-5) diagnostic criteria for BED. A PubMed search restricted
to titles and abstracts of English-language reviews, meta-analyses, clinical trials, randomized controlled trials, journal articles, and letters using human participants was conducted on
August 7, 2015, using keywords that included “binge eating disorder,” DSM-5, DSM-IV, guilt,
shame, embarrassment, quantity, psychological, behavior, and “shape and weight concerns.”
Of the 257 retrieved publications, 60 publications were considered relevant to discussions
related to DSM-5 diagnostic criteria and were included in the current review, and 20 additional
references were also included on the basis of the authors’ knowledge and/or on a review of
the reference lists from relevant articles obtained through the literature search. Evidence supports the duration/frequency criterion for BED and the primary importance of loss of control
and marked distress in identifying individuals with BED. Although overvaluation of shape/
weight is not a diagnostic criterion, its relationship to the severity of BED psychopathology
may identify a unique subset of individuals with BED. Additionally, individuals with BED
often exhibit a clinical profile consisting of psychiatric (eg, mood, obsessive–compulsive, and
impulsive disorders) and medical (eg, gastrointestinal symptoms, metabolic syndrome, and type
2 diabetes) comorbidities and behavioral profiles (eg, overconsumption of calories outside of
a binge eating episode and emotional eating). Future revisions of the BED diagnostic criteria
should consider the inclusion of BED subtypes, perhaps based on the overvaluation of shape/
weight, and an evidence-based reassessment of severity criteria.
Keywords: binge eating disorder, diagnosis, obesity, psychotherapy, pharmacotherapy,
psychopathology
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and extreme, 14); severity level can be increased to reflect
other symptoms and functional disability.1
BED was recognized as a clinical condition as early as
1959.2 However, it first appeared in the DSM-IV 3 as a provisional diagnosis that required further study. Thus, individuals
meeting the criteria for BED were diagnosed with an eating
disorder not otherwise specified.3 Subsequent research has
established BED as a distinct eating disorder, which led to
its inclusion in the DSM-5.1
Given the recognition of BED in the DSM-5 as a distinct
eating disorder and the fact that the DSM-5 criteria do not
differ substantially from the provisional criteria originally
proposed in the 1990s,4,5 it is worth reviewing the literature
supporting this diagnosis to better understand the strengths
and limitations of the current diagnostic criteria. This
is particularly important because the estimated lifetime
prevalence of BED in the US based on DSM-IV criteria
(1.9%–2.8%) exceeds that of both BN (~1.0%) and AN
(~0.6%).6,7 An improved understanding of the basis for the
BED diagnostic criteria will be useful information for future
DSM revisions and potentially benefit treatment selection
and/or predict treatment response.
This qualitative review focuses on describing the characteristics of BED with reference to DSM-5 diagnostic criteria
and highlights the aspects of the DSM-5 diagnostic criteria
requiring further consideration, including the definition of
what constitutes a “large amount of food” with reference
to binge eating, and the lack of inclusion of overvaluation
of shape and weight as a diagnostic criterion. Thus, this
review summarizes the evidentiary basis for the DSM-5 BED
diagnostic criteria; the factors that differentiate BED from
other eating disorders and obesity; and the comorbidities,
psychopathologies, functional disabilities, and impaired
quality of life (QoL) associated with BED. Based on this
evidence, a discussion on the limitations of the current
diagnostic criteria and recommendations for future research
requirements are provided.

Methods
Literature review
A PubMed search restricted to titles and abstracts of Englishlanguage systematic reviews, meta-analyses, clinical trials,
randomized controlled trials, journal articles, and letters
that used human participants was conducted on August 7,
2015. Search terms used were (“binge eating disorder” OR
“binge eating”) AND (DSM-5 OR DSM-IV) AND (“loss of
control” OR guilt OR shame OR embarrassment OR quantity
OR treat OR treatment OR psychological OR behavior OR
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“shape and weight concerns” OR “shape/weight concerns”
OR “body image” OR “shape and weight overvaluation”
OR “shape/weight overvaluation” OR severity OR specifier OR subtyping OR “binge eating frequency” OR comorbid OR comorbidities). Although BED can be identified in
children and adolescents,8,9 only a few meet all symptom
criteria for BED. Therefore, the current review focuses only
on the adult literature. It should also be noted that shape and
weight concerns are not currently included in the diagnostic
criteria for BED. However, it has been suggested that they
should be included as a diagnostic specifier or can be used
for dimensional rating of severity in BED.10 As such, this
term was included in the literature search so that the evidence
base for this topic could be reviewed. Additional references
were included based on the authors’ knowledge of relevant
articles and on a review of the reference lists from relevant
articles obtained through the literature search.

Results
Summary of search results
A total of 257 publications were retrieved through the
PubMed search. Of these, 197 were eliminated as being
irrelevant to the objectives of this study based on a review
of the published abstracts, and the remaining 60 publications
were considered relevant to discussions related to DSM-5
diagnostic criteria and were included in the current review.
An additional 20 references were also included based on
the authors’ knowledge of relevant publications and/or on a
review of the reference lists from relevant articles obtained
through the literature search.

Evidence base for DSM-5 BED
diagnostic criteria
There is variability in the amount of evidence available for the
individual diagnostic criteria for BED. However, in a study
that examined the heritability of BED, factor loadings for each
of the diagnostic criteria for BED were found to be highly
associated with the propensity toward BED. This finding indicates that each of the BED diagnostic criterion is related to a
unidimensional construct (ie, a single psychiatric diagnosis).11
The following sections describe the supportive evidence for
specific BED diagnostic criteria, highlight the limitations of
some of these criteria, and discuss the clinical phenotypes
that are not included in the DSM-5 BED criteria.

Amount of food consumed
Although the BED diagnostic criteria refer to objective
binge eating episodes (eg, eating a larger amount of food in
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a discrete period than what a typical person would consume
under similar circumstances and eating a large amount of
food when not physically hungry),1 the role of subjective
binge eating episodes (eg, eating what is “perceived” by
that person to be a large amount of food even if it is not an
amount that is typically considered large)12–14 is not addressed
in the DSM-5 BED diagnostic criteria. Individuals who report
only having subjective binge eating episodes do not meet
DSM-5 diagnostic criteria for BED. Some justification for
excluding subjective binge eating episodes from the BED
diagnostic criteria can be derived from the fact that no published comparative data on subjective binge eating episodes
in individuals with versus without BED are available.
In contrast, the frequency of objective binge eating episodes
has been shown to be higher in obese individuals with BED
than in obese individuals without BED.15,16 Furthermore, the
limited available data on subjective binge eating episodes in
individuals with BED or in those meeting partial criteria for
BED indicate that there are few meaningful differences in
binge eating severity or psychopathology when individuals
exhibiting subjective versus objective binge eating episodes
are compared.12,14 To more clearly delineate the relative
importance of subjective versus objective binge eating
episodes in BED, systematic assessment of the proportion of
individuals with DSM-5-defined BED who report subjective
binge eating episodes and the relative proportions of subjective versus objective binge eating episodes reported by these
individuals needs to be carried out.
In further regard to the amount of food consumed in
BED, it is also difficult to definitively state what constitutes
“an amount of food that is definitely larger than what most
people would eat during a similar time period under similar
circumstances” because this definition is based on clinical
judgment, which varies across health care professionals. The
fact that obese individuals with BED often overconsume
food relative to obese individuals without BED during
the periods of normal consumption also complicates this
issue.17–19 In conclusion, there is a degree of uncertainty about
what constitutes a “large amount of food” with reference to
binge eating and, perhaps due to the limited available data
on individuals with BED, whether subjective binge eating
should be considered in the BED diagnostic criteria.

Loss of control
Among the diagnostic criteria for BED, a sense of loss of
control over eating has been shown to be foundational to
the BED diagnosis.20–26 In a study on obese females being
assessed for bariatric surgery, the frequency of reporting loss
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of control over eating was higher in participants who selfreported binge eating (75%) than in those who self-reported
only overeating (22%).26 In another study that examined
BED diagnostic criteria using the Questionnaire of Eating
and Weight Patterns, loss of control over eating was reported
in 84% of the self-referred individuals who reported binge
eating or compulsive overeating to be problematic compared
with 35% of controls who did not.25 The odds of experiencing loss of control over eating were 3.6 times greater in
individuals with BED than in individuals without BED after
controlling for affective state and caloric intake, which suggests that loss of control is an inherent component of BED.20
In support of this conclusion, when females with BED were
asked to define binge eating, 82% included loss of control.21
In this same study, responses of the type “feeling totally out
of control” and “a binge is not being able to stop eating or
stop before it’s all gone” were typical across participants.21
However, at least one study that compared treatment-seeking
obese females with BED to obese females without BED (but
did not report a loss of control regarding their eating) did not
report consistent differences in eating symptoms or general
psychopathology between these groups.27 The authors suggested that the lack of differentiations in this study could
partly be due to the fact that all participants in the study were
treatment-seeking and may have been exhibiting higher-level
eating disorders and psychopathology than non-treatmentseeking individuals who are obese.

Binge eating episode characteristics
There is limited evidence in the published literature to support the individual characteristics of a binge eating episode
described in the DSM-5. Of the five indicators of impaired
control listed in the DSM-5 (ie, determinants of loss of control
during a binge eating episode), eating large amounts of food
when not hungry and eating alone because of embarrassment
were found to be the best predictors of a BED diagnosis.22

Marked distress
The published literature indicates that BED is associated with
general psychiatric distress15,28–30 and, more specifically, with
marked distress in regard to binge eating.2,11,23,29,31–34 As early
as 1959, case reports of Stunkard indicated that marked
distress was reported in people who binge eat.2 High levels
of distress related to binge eating are reported in individuals
with BED who are normal weight and in individuals with
BED who are obese, suggesting that the distress is not simply
a consequence of comorbid obesity.33 The integral nature
of binge eating–related distress in individuals with BED is
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supported by genetic studies, which indicate that marked
distress is a heritable component of BED.11
Individuals with BED demonstrating marked distress
related to binge eating exhibit increased levels of eating
disorder pathology and depressive symptoms compared with
individuals meeting all BED criteria except marked distress
and with individuals who are obese but do not exhibit binge
eating or purging behavior.31 Furthermore, levels of distress
associated with binge eating in individuals with BED have
been reported to differ as a function of the presence of
overvaluation of shape and weight, which is associated with
increased distress,32 and race/ethnicity. Although distress is
reported across all examined races/ethnicities, higher levels
of distress associated with binge eating are more likely to
be reported in individuals who are Latino or Caucasian
than in individuals who are Asian or African-American.34
Therefore, although the level of distress may vary across
subpopulation, the overall literature provides support for
the legitimacy of the DSM-5 marked distress criterion for
BED.2,11,23,29,31–34

Binge eating frequency and duration
Although there was controversy regarding the binge eating frequency criterion in the DSM-IV – text revision
(DSM-IV-TR; ie, at least twice a week for 6 months35), which
was chosen to set a high threshold for diagnosing BED in the
absence of empirical support for a less stringent criterion,36
the currently available data support the less stringent criterion
(ie, at least once a week for 3 months1) of the DSM-5.29,37–40
For instance, females with subthreshold BED (defined by a
binge eating frequency of at least once a month for 6 months)
exhibited eating disorder patterns and psychiatric symptoms,
with the exception of shape concern, similar to those of
females with full-syndrome BED (as defined by DSM-IV-TR
criteria).29 Furthermore, individuals with subthreshold BED
(binge eating episodes less than twice a week but at least once
per 28 days or eating 800 kcal per binge at least twice per
week) did not differ in eating psychopathology, as measured
by the dietary restraint, disinhibition, and hunger dimensions
of the Three-Factor Eating Questionnaire, from those meeting
full DSM-IV-TR BED criteria.38
It has been suggested that the revised frequency/
duration criterion for BED in the DSM-5 will increase the
ability to detect binge eating pathology without markedly
changing lifetime prevalence,40 which would be indicative
of increased diagnostic sensitivity (ie, the percentage of
individuals with BED correctly identified as having this
condition would increase). A study estimated that the

2216

Powered by TCPDF (www.tcpdf.org)

submit your manuscript | www.dovepress.com

Dovepress

Dovepress

DSM-5 BED criteria would produce a relative increase
in the lifetime prevalence of ~3%, with the resulting total
lifetime prevalence of BED in the United States increasing to 3.6% in females and 2.1% in males.39 Another study
estimated that lifetime prevalence would increase by 0.18%
when the frequency/duration criterion shifted from 8 times
per month for 6 months (the DSM-IV-TR criterion) to 4
times per month for 3 months (as this study was conducted
before the release of the DSM-5 BED criteria, it utilized the
approximate DSM-5 frequency criterion that later became
the actual criteria).40 Based on the available evidence, the
less stringent binge eating frequency/duration criterion for
BED used in the DSM-5 is likely to increase the sensitivity
of BED diagnosis (ie, ensure that individuals with BED
are properly diagnosed) without markedly changing its
specificity (ie, ensure that individuals without BED are not
diagnosed) relative to the DSM-IV-TR provisional criteria.
Overall, the available evidence supports the less stringent
frequency/duration criteria of the DSM-5 compared with the
provisional criteria of the DSM-IV-TR,29,37–40 even though
the exact criteria of the DSM-5 have not yet been specifically validated.

Differentiating BED from BN or AN
The DSM-5 diagnostic criteria for BED are intended to identify individuals who have significant eating pathologies that
are distinct from those observed in other eating disorders.24
Diagnostically, BED is distinguished from BN and from
AN-BE/P by the lack of recurrent compensatory behaviors
in BED, which are necessary for the diagnosis of BN and
may be present in AN-BE/P but are not required.1 In addition,
DSM-5 diagnostic criteria for BED do not include shape and
weight concerns, which are included in the criteria for both
AN and BN.1 However, it should be reiterated that a substantial proportion of individuals with BED report shape and
weight concerns.10,30,32,41 Perhaps because of these diagnostic
distinctions, lifetime diagnoses of AN or BN in individuals
who also meet BED criteria have generally been reported to
be low (1.5% and 5.9%, respectively) in adults.42 However,
it should also be noted that diagnostic crossover was reported
to be higher (BN to BED [23%] and BED to BN [20%]) in a
community sample of adolescent females,43 suggesting that
transitions between BN and BED may be more common
prior to adulthood.
BED differs from AN and BN in terms of prevalence, age
of onset, and eating behaviors and pathologies.6,7,10,16,31,44–46
The relative lifetime prevalence of BED in both males and
females (2.0% in males and 3.5% in females) is higher than
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that observed in BN (0.5% vs 1.5%) or AN (0.3% vs 0.9%).6
BED also differs from BN in that it has a later age of onset
(mean age, 23.3 vs 20.6 years; interquartile range for age
of onset, 15.5−27.2 years for BED and 14.5−22.9 years
for BN) and may have a lower persistence (median years
in episode, 4.3 vs 6.5),7 although others propose that the
course is comparable.1 In individuals with BED, scores on
measures of dietary and cognitive restraint are lower than
that in individuals with BN.10,16,31,44 Individuals with BED
also exhibit a significantly lower frequency of binge eating
episodes than do individuals with BN.10,16 However, unlike
individuals with BN, individuals with BED overconsume
food during both binge eating episodes and non-binge eating
episodes.45,46 Overall,6,7,10,16,31,44–46 there is clear evidence that
BED is distinct from AN and BN.

Binge eating disorder severity criteria
The DSM-5 provides severity criteria for BED, with the minimum level of severity based on the number of weekly binge
eating episodes (mild, 1–3; moderate, 4–7; severe, 8–13;
and extreme, 14), and the severity level can be increased
to reflect other symptoms and functional disability.1 As of
the release of the DSM-5 in 2013, there was no empirical
evidence to support the recommended BED severity criteria of the DSM-5. In two studies published in 2015, the
BED severity categories of the DSM-5 were evaluated in
clinical and community populations of adults diagnosed with
BED.47,48 The percentages of participants in these studies
(clinical population vs community population) categorized
as having BED of mild, moderate, severe, and extreme
severity based on DSM-5 criteria were 39.7% versus 78.1%,
47.4% versus 19.8%, 10.0% versus 1.8%, and 3% versus
0.3%, respectively,47,48 indicating that the clinical population
exhibited more severe BED symptoms as would be expected.
When the BED severity groups in the clinical population were
compared across clinical characteristics (Eating Disorder
Examination [EDE] Questionnaire global and subscale scores
and Beck Depression Inventory scores), eating pathology
significantly increased as a function of BED severity on
three EDE subscales (ie, eating concern, shape concern, and
weight concern) and on Beck Depression Inventory score.48
In the community population, increased BED severity was
associated with increased EDE global and subscale scores.47
Based on these data, the categorization of BED severity as
a function of weekly binge eating episodes appears valid.
However, data providing support for the modification of BED
severity based on other symptoms or functional disability
are not available.

Neuropsychiatric Disease and Treatment 2016:12
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Evidence base for factors not
included as diagnostic criteria
Obesity
Although obesity is associated with BED, it is not included
as a diagnostic criterion for BED and the DSM-5 indicates
that BED is distinct from obesity.1 BED is reported across
body mass index (BMI) categories but is most common in
obese individuals (36.2%–42.4%).6,7 A substantial minority
of individuals seeking weight loss treatment also have a BED
diagnosis (13%−27%).28,49–51 Among obese individuals, those
meeting the DSM-5 BED diagnostic criteria are a meaningful and distinct subgroup. Obese individuals with BED have
poorer psychological functioning (eg, higher depression,
lower self-esteem, and more emotional eating and shape and
weight concerns) than obese individuals without BED.15,16,50,52
In addition, compared with obese individuals without BED,
obese individuals with BED exhibit distinct eating behaviors
beyond binge eating. For instance, obese individuals with
BED consume more calories than obese individuals without
BED when asked to binge eat in a laboratory setting17–19,53 and
when asked to eat a normal (ie, nonbinge) meal in a laboratory
setting.18,19 These findings raise the unanswered question of
why obese individuals with BED do not have substantially
higher BMI than obese individuals without BED because
individuals with BED consume more calories overall and
have similarly low levels of physical activity.54
The concept that BED is a phenotype that is distinct from
obesity is further validated by genetic studies.11,55,56 These
studies indicate that BED is heritable,11,55,56 that BED clusters
in families independent of the presence of obesity, and that
individuals with a family history of BED are at greater risk
of obesity in adulthood than those with a family history of
obesity but not with BED.56 Overall, the literature emphasizes
that there are distinct differences between obese individuals
with and without BED.15–19,50,52,53

Overvaluation of shape and weight
There has been controversy regarding the role of overvaluation of shape/weight in BED and its lack of inclusion as a
diagnostic criterion for BED,24,57 in part due to discrepancies in the published literature. Overvaluation of shape/
weight was clinically recognized in individuals with BED
in the 1990s.58 The literature suggests that overvaluation
does not simply reflect obesity-related concerns or distress.
Rather, independent of BMI, it is reliably associated with
the severity of eating pathology, psychological distress, and
negative prognostic significance10,15,30,32,41,59 and with worse
treatment outcomes60–62 in individuals with BED. However,
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a substantial proportion (~40%) of individuals with BED
do not exhibit overvaluation of shape and weight,10,32,41 in
marked contrast to BN where most individuals (95%) exhibit
overvaluation.10
Despite this discrepancy, individuals with BED who
exhibit clinically relevant overvaluation of shape/weight
(defined as scores of 4 on either overvaluation item of
the EDE) tend to have more severe eating disorder pathology, as evidenced by higher scores on the eating concerns
and dietary restraint subscales of the EDE than those who
exhibit subclinical overvaluation of shape/weight (defined
as scores of 4 on both overvaluation items of the EDE).10
Consistent with a preoccupation with shape/weight, body
checking behavior (eg, frequent weighing or measuring of fat
deposits) in obese females with BED is positively correlated
with overvaluation of weight and depressive symptoms and is
negatively correlated with self-esteem (although similar correlations were not found in males with BED).63 Overvaluation
of shape/weight has also been found to be associated with
psychiatric and social function impairments (eg, depression,
anxiety, decreased self-esteem, and functional impairments)
in individuals with BED.15,30,32,59 Individuals with BED who
do not demonstrate shape/weight overvaluation have been
reported not to differ substantively from obese individuals
without BED in terms of eating disorder pathology and
functional impairment.59
In sum, there is evidence demonstrating that overvaluation of shape/weight is strongly related to eating pathology
severity in individuals with BED and that it has negative
prognostic significance in individuals with BED.10,15,30,32,41,57,59
This suggests that overvaluation of shape/weight should
be considered as a diagnostic specifier, which designates a
subtype of BED, or a modifier that could increase the index
of BED severity. If it were a required diagnostic criterion, it
would result in the exclusion of a substantial number of individuals who otherwise do exhibit significant pathology and
distress10 because a substantial proportion of individuals with
BED do not exhibit overvaluation of shape/weight.10,32,41

Comorbidities, psychopathologies,
functional disabilities, and impaired QoL
As described earlier in this review, the DSM-5 diagnostic
criteria for severity based on binge eating frequency can be
adjusted on the basis of the presence of other symptoms and
by the degree of functional disability.1 Although there is no
empirical basis for adjusting the severity based on functional
disability, a substantial body of evidence (see Davis64 and
Sheehan and Herman65 for recent reviews) suggests that BED
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is associated with psychiatric and medical comorbidities,
functional disability, and impaired QoL.6,7,42,50,62,66–76

Psychiatric comorbidities and psychopathologies
Individuals with BED report higher rates of major depressive
disorder, posttraumatic stress disorder, generalized anxiety
disorder, obsessive–compulsive disorder, panic attacks,
impulse control disorders, and substance abuse than individuals without BED.6,7,42,50,62,66–68 For example, the lifetime
prevalence for any mood disorder and anxiety disorder among
individuals with BED has been estimated to range from 46%
to 54% and from 37% to 65%, respectively.6,7,42
The relationship between BED and psychiatric comorbidities may be complex and influenced by factors that
include comorbid disease severity and race.44,77–81 Among
individuals with BED, the severity of depression or anxiety
symptoms can influence the likelihood of binge eating.77
Similarly, emotional eating (ie, eating in response to negative emotions and anxiety) correlates with binge eating and
most eating psychopathology measures in obese individuals
with BED.78,79 Regarding race and ethnicity, individuals with
BED who are Black or Hispanic have been found to be more
than twice as likely as individuals with BED who are White
to have a comorbid mood and anxiety disorder.80 Elevated
psychiatric comorbidities in BED can occur independently
of obesity and weight status, with studies reporting that
individuals with BED who are obese and individuals with
BED who are not obese have similar levels of depressive
symptoms.44,81
In addition to psychiatric comorbidities, certain personality profiles and psychopathologies in individuals with BED
are associated with binge eating behaviors.50,82 In a study of
obese females with BED, binge eating severity was correlated
with paranoid ideas, psychoticism, and interpersonal
sensitivity.50 Furthermore, individuals with BED exhibit
interpersonal problems, which are negatively correlated with
age at first binge, and less flexible interpersonal styles, which
increase the likelihood of meeting BED diagnostic criteria
at a young age.82
Taken together, this is a substantial evidence base indicating that BED is associated with increased psychiatric
comorbidity and psychopathology and distinctive personality
profiles.44,50,77–82 It is important for clinicians to be aware of
these comorbid conditions, because they may be the manifest
reasons that individuals with BED seek treatment, particularly
if they are not aware that BED is an actual disorder. Furthermore, the personality profiles, presence of specific comorbidities, and their severity may influence treatment strategies.
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Nonpsychiatric comorbidities and medical profiles
BED is associated with nonpsychiatric medical comorbidities
that include sleep disturbances, type 2 diabetes, metabolic
syndrome, and gastrointestinal distress.69–73 A large percentage of individuals with BED (40%) meet the criteria for
metabolic syndrome.69,70 Consistent with this finding, in a
5-year longitudinal study, individuals with BED who were
obese were found to be at increased risk for developing components of metabolic syndrome compared with individuals
without BED who were BMI-matched to those with BED.74
In a study of weight loss surgery candidates, ~8% of individuals met diagnostic criteria for both type 2 diabetes and
BED, with black race and male sex being strong indicators
of the co-occurrence of these disorders.71

Functional disability and QoL
Data on QoL and functional disability in individuals with
BED are relatively limited, but publications to date do support the concept that BED is associated with impaired QoL
and with increased functional disability.7,73,75,76,83 Based on the
Medical Outcomes 36-item Study Short-Form Health Survey,
all domains of health-related QoL are impaired in individuals
with BED relative to the normative US population and on the
emotional role limitation, mental health, and social functioning domains relative to obese individuals without BED.76
Furthermore, in a study of females conducted at primary
care and gynecologic clinics throughout the US, BED was
associated with worse health-related QoL on all domains of
the Medical Outcomes 20-item Study Short-Form Health
Survey compared with females without psychiatric disorders.73 In regard to functional disability, BED is associated
with impaired role attainment relative to individuals without
BED as measured by females with BED (but not males) being
less likely to marry and males with BED (but not females)
being less likely to be employed.75 On the Sheehan Disability
Scale, ~50% of individuals with BED reported some level of
role impairment.7 In a randomized, placebo-controlled study
of topiramate,83 mean Sheehan Disability Scale total scores
at baseline (~12 points) were indicative of mild-to-moderate
functional impairment.84

Limitations of the DSM-5 diagnostic
criteria for BED
The DSM-5 diagnostic criteria for BED are intended to
identify a population of individuals whose psychopathologic
and behavioral profiles are distinct from other eating disorders and obesity. However, there are several limitations of
the current criteria and outstanding issues that remain to be
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addressed. The strongest evidence supporting the DSM-5
diagnostic criteria is available for the loss of control,20–24
marked distress, 2,11,23,29,31–34 and the frequency/duration
criteria.29,37–40 Although the presence of loss of control over
eating in BED is empirically supported in the published
literature,20–24 the role of subjective binge eating episodes in
BED has not been extensively studied, and what constitutes
consuming an amount of food that is “definitely larger than
what most people would eat under similar circumstances…”1
during an objective binge eating episode is not well defined
and is based on clinical judgment.
An index of BED severity is included in the DSM-5, which
establishes a minimum level of severity based on the number
of binge eating episodes per week (mild, 1–3; moderate, 4–7;
severe, 8–13; and extreme, 14) and allows for increases in
severity based on the presence of comorbidities and functional
disabilities.1 This represents an expansion of the criteria compared with the DSM-IV-TR, in which severity criteria were
not included.35 Although there is some evidence supporting
the new severity criterion based on the number of weekly
binge eating episodes,47,48 the degree to which comorbidities,
other symptoms, or functional disability influence severity is
not clear. Furthermore, the impact of the method that is used
to assess symptom severity needs to be clarified because
symptom level could vary between patient self-report versus
physician-administered clinical interview. In addition, a systematic review reported that some self-reported binge eating
measures exhibit better psychometric properties than others
but that further study is required in terms of the validity and
reliability of most binge eating measures.85
Overvaluation of shape/weight is not addressed in the
DSM-5, despite the fact that it has been recognized by
researchers as an important feature of BED.24,57 Overvaluation of shape/weight is known to have prognostic value for
BED32,57 and is included as part of the diagnostic criteria for
BN and AN.1 Although there is empirical evidence for not
including overvaluation of shape/weight as a required criterion for BED,10 its total exclusion from the DSM-5 criteria is
not warranted based on its prognostic value and association
with the severity of eating disorder pathologies in individuals
with BED.10,15,30,32,41,57,59 Using the overvaluation of shape and
weight to designate a distinct subtype of BED or as a modifier
of BED severity should be taken into consideration.
Although individuals meeting DSM-5 criteria for BED
share commonalities (eg, more likely to be overweight, to
be female, and to have elevated anxiety and/or depression),
there are important individual differences among individuals with BED. Future research should examine the utility
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of including distinct subtypes of BED in the diagnostic
criteria. In support of this recommendation, a factor analysis
from one study identified two BED subtypes (a pure dietary
subtype and a negative affect BED subtype), with the latter
exhibiting a higher frequency of binge eating episodes and
sensitivity to punishment, as measured by the Sensitivity
to Punishment and Sensitivity to Reward Questionnaire.86
Another analysis identified four distinct BED classes (Class
1: increased physical activity levels and lower BMI; Class
2: high levels of binge eating, shape/weight concerns, compensatory behaviors, and negative affect; Class 3: high levels
of binge eating with low levels of exercise or compensation;
and Class 4: high BMI, frequent overeating with fewer
binge episodes, and no compensatory behavior).87 Of note,
the potential existence of a BED subtype characterized by
compensatory behavior complicates the current diagnostic
guidelines and renders indistinct the differences between
BED and other eating disorders. Lastly, although individuals
with BED who are not obese have been reported to be similar
to individuals with BED who are obese in many ways,44,81
it has been reported that individuals with BED who are not
obese may display more dietary and cognitive restraint than
individuals with BED who are obese.81 Although not all studies have replicated this finding,44 the potentially increased
restraint in individuals with BED who are not obese may
blur the distinction between BED and nonpurging BN (ie,
individuals with BN who compensate through dietary fasting
or excessive exercising rather than purging).

Conclusion
The diagnostic entity of BED, which has been recognized in
clinical settings and the research literature for 50 years,2
is a heterogeneous and complex disorder. Individuals diagnosed
with BED often exhibit a unique clinical profile consisting of
psychiatric6,7,42,50,62,66–68 (eg, mood, obsessive–compulsive, and
impulsive disorders) and nonpsychiatric medical69–73 (eg, sleep
disturbance, gastrointestinal symptoms, metabolic syndrome,
and type 2 diabetes) comorbidities, psychopathologies32,57,63
(eg, overvaluation of shape and weight), and personality/
behavioral traits17–19,50,78,79,82,88 (eg, overconsumption of
calories, emotional eating, and interpersonal problems).
Because comorbid conditions may be one of the reasons
individuals with BED seek treatment, physicians need to be
aware of their presence. Although evidence indicates that BED
is more prevalent than both AN and BN6,7 and is associated
with worse QoL73,76 and increased functional disability,7,75,83
BED continues to be underrecognized, underdiagnosed, and
undertreated in clinical settings.7

2220

Powered by TCPDF (www.tcpdf.org)

submit your manuscript | www.dovepress.com

Dovepress

When considering patients with putative BED, health care
professionals should focus on the presence of clinical indicators and risk factors to aid in diagnosis.89 These indicators can
include obesity and clinically significant weight gain (5%
of body weight) in the past year, psychiatric and medical
comorbidities, and a family history of BED. There are also
assessment tools that can be used by health care professionals
when assessing the patients for potential BED. These include
the validated seven-item binge eating disorder screener
(BEDS-7),90 the validated Eating Disorder Assessment for
the DSM-5,91 and the Eating disorder Screen for Primary
Care (ESP).92 The ESP and Eating Disorder Assessment for
the DSM-5 are limited in that they do not focus specifically
on BED, as does the BEDS-7. Furthermore, the BEDS-7 and
ESP are screeners that are not intended to be used as diagnostic
tools; individuals who screen positive on the BEDS-7 or ESP
should be referred to a specialist for a formal diagnosis.
With the release of the DSM-5 diagnostic criteria for
BED and its inclusion in the main text of the DSM-5 as a
distinct eating disorder, it is expected that BED will become
increasingly recognized, diagnosed, and treated by both
psychiatrists and primary care physicians. Based on a review
of the published literature in PubMed, empirical evidence
supports the legitimacy of the duration/frequency criterion
for BED and the primary importance of loss of control over
eating and marked distress in BED. However, there is a lack
of clarity regarding what constitutes a “large amount of food”
with reference to binge eating and whether subjective binge
eating should be considered in the BED diagnostic criteria.
These findings should be considered in light of the fact
that only a single database was used in the current review.
In addition, although overvaluation of shape/weight is not
a diagnostic criterion in the DSM-5, the published literature
suggests that it is strongly related to eating pathology severity in individuals with BED and may identify an important
subgroup of individuals with BED or serve as an index of
severity. Future revisions of the DSM criteria for BED should
consider whether to include the undue influence of body
shape and weight on self-evaluation as a specifier indicating
a BED subtype.
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